CME vs JANX · P/E 22, rev $3.59B vs rev $10.3M
CME Group Inc (CME) versus Janux Therapeutics Inc (JANX) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
CME currently screens at market cap $91.25B and trailing P/E 21.9. JANX currently screens at market cap $1.49B.
Not investment advice. Open the CME and JANX stock pages for the full models.
Not investment advice.